carboplatin,gemcitabine,paclitaxel,vinorelbine,cisplatin,nivolumab,docetaxel,pemetrexed,ipilimumab,pembrolizumab
merck,bms
['keynote,671', 'check,mate,816', 'nsclc', 'keynote 671', 'sclc']
it is difficult to give check mate to " check mate 816 " in nsclc . post keynote 671 presentation is becoming more evident. #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists